CN1053828C - Oral medicine for treating acute cerebrovascular disease - Google Patents
Oral medicine for treating acute cerebrovascular disease Download PDFInfo
- Publication number
- CN1053828C CN1053828C CN95117047A CN95117047A CN1053828C CN 1053828 C CN1053828 C CN 1053828C CN 95117047 A CN95117047 A CN 95117047A CN 95117047 A CN95117047 A CN 95117047A CN 1053828 C CN1053828 C CN 1053828C
- Authority
- CN
- China
- Prior art keywords
- acute cerebrovascular
- cerebrovascular disease
- medicine
- radix
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an oral medicine for treating acute cerebrovascular diseases, which is composed of traditional Chinese medicines of keel, red sage root, astragalus root and Korean ginseng through boiling, vacuum concentration and subpackage. The cure rate of medicine reaches more than 85%, the disability rate is smaller than 0.05%, and hospital clinical application shows that the medicine is a highly effective medicine for treating acute cerebrovascular diseases.
Description
The present invention relates to a kind of medicinal preparation for oral administration for the treatment of acute cerebrovascular disease, particularly a kind of medicinal preparation for oral administration of the treatment acute cerebrovascular disease based on Chinese medicines such as Os Draconis.
Acute hemorrhagic cerebrovascular diseases is one of principal disease that endangers now middle-older patient life.Almost be to adopt western medicine therapy at present, but treatment rate is also not high, generally only reaches about 80%, disability rate is not low yet simultaneously, generally up to about 30%.
Domestic in recent years appearance is crossed and is used Ahylysantinfarctase, or and Radix Polygoni Ciliinerve, Flos Carthami, Rhizoma Chuanxiong, and with Chinese medicine methods such as oral Hirudo powder, though certain curative effect is arranged, but still not ideal enough.
The object of the present invention is to provide a kind of is the medicament of the treatment acute hemorrhagic cerebrovascular diseases of Main Ingredients and Appearance with the Chinese medicine Os Draconis, its treatment rate of living is up to more than 85%, disability rate has only the new Chinese medicine agent below 0.05, and commercially available medicine of the present invention is called tonifying YIN, logical blood, charismatic lifesaving soup.
Embodiment of the present invention are as follows: with Os Draconis, Radix Salviae Miltiorrhizae, the Radix Astragali and Korean Ginseng, Hirudo, Radix Notoginseng Six-element Chinese medicine, the water infusion concentrates medicinal liquid then and forms specifically fill a prescription following (weight portion) under vacuum:
Os Draconis: 25-35 Hirudo: 12-18
The Radix Astragali: 60-70 Radix Notoginseng: 28-32
Korean Ginseng: 22-27 water: 1500-1700 milliliter
Radix Salviae Miltiorrhizae: 60-70
Concrete grammar is: above-mentioned Six-element medicine is added in the general heating kettle that has a stirring by above-mentioned amount, its effective in cure composition of heating for dissolving under (about 95-102 ℃) under the little boiling of maintenance, then medicinal liquid is moved in the universal vacuum evaporation boiler to be controlled under 85-92 ℃ and concentrate in the vacuum of the 600-650 millimeter of water and temperature, general concentrated solution volume just becomes oral medication acute cerebrovascular disease medicament of the present invention for concentrated not preceding about 1/3.
Certainly can further concentrate and make capsule.
This medicament adopts Chinese medicine, Os Draconis are to be used for suppressing the hyperactive liver and subsiding YANG, tranquillizing and allaying excitement, restraining astringent or styptic treatment for spontaneous sweating is to improve the side shoot blood circulation to prevent cerebrovascular acute and tardy property convulsion twin with Radix Salviae Miltiorrhizae, the Radix Astragali, accelerate microcirculation, velocity of blood flow, increase effects such as capillary bed, promote the reparation and the regeneration of bleeding tissue, quicken the recovery of brain siddhi energy.As for the purpose that adopts Korean Ginseng is because of its energy stimulating central nervous system system, accelerates the conduction of neural impulse, and Radix Notoginseng and Hirudo are a kind of good blood circulation promoting and blood stasis dispelling, the good medicine that dispels the wind of promoting blood circulation.
The present invention is accurate for basic according to diagnostic criteria and smelting criterion that second national cerebrovascular meeting worked out, clinical treatment to 500 routine acute hemorrhagic cerebrovascular diseases, its cure rate and effective percentage are respectively 89.7% and 95%, disability rate is less than 0.05, and its conclusion is that this medicament has possessed with blood, the feature and the effect of invigorate blood circulation, loose blood, promoting the circulation of blood, removing blood stasis blood, main stagnant blood.
Below preference the present invention is described in detail, but do not mean that and limit the scope of the invention.
Example 1, a general stirred volume that has is in 250 liters the heater, drop into 2.5 kilograms of Os Draconis, 6.0 kilograms of Radix Salviae Miltiorrhizaes, 14.0 kilograms of the Radixs Astragali, 2.2 kilograms of Korean Ginseng, 1.2 kilograms of Hirudos, 150 kilograms in 2.8 kilograms of Radix Notoginseng and water start stirring, and be heated to 100-102 ℃, keep little and boiled 2 hours.Stop heating, with universal filter elimination medicinal residues, must slightly be 135 kilograms of little brown extracting solution, this extracting solution is moved in the universal vacuum evaporating kettle, controlled pressure is 620 ± 20 millimeters of water, temperature is to concentrate till concentrated solution is 45 kilograms in 89 ° ± 2 ℃, and then this concentrated solution being divided into every bottle is that 10 milliliters oral medicine just becomes oral living of the present invention and treats the acute cerebrovascular disease medicament.
Example 2 is removed prescription and is changed 3.5 kilograms of Os Draconis into, 7.0 kilograms of Radix Salviae Miltiorrhizaes, 16 kilograms of the Radixs Astragali, 2.7 kilograms of Korean Ginseng, 1.8 kilograms of Hirudos are outside 170 kilograms in 3.2 kilograms of Radix Notoginseng and the water, all the other conditions are identical with example 1,50 kilograms of concentrated solutions, also being packed as every bottle is 10 milliliters oral medicine of the present invention.
Advantage of the present invention is:
1. than the treatment rate height of Western medicine, disability rate is low, and being known as is a kind of new having The effect medicine.
2. method for making is simple and reliable, can adopt common apparatus.
The present patent application proves with the People's Hospital, Xiping County, Henan Province.
Claims (2)
1. oral medication acute cerebrovascular disease medicament is characterized in that it is to be made by the raw material of following weight portion:
Os Draconis: 25-35 Hirudo: 12-18
Radix Salviae Miltiorrhizae: 60-70 Radix Notoginseng: 28-32
The Radix Astragali: 140-160
Korean Ginseng: 22-27
Water: 1500-1700.
2. oral medication acute cerebrovascular disease medicaments preparation method is characterized in that:
(1) set of dispense ratio, weight portion:
Os Draconis: 25-35 Hirudo: 12-18
Radix Salviae Miltiorrhizae: 60-70 Radix Notoginseng: 28-32
The Radix Astragali: 140-160
Korean Ginseng: 22-27
Water: 1500-1700.
(2) component with (1) is that in the general heating device 100 ℃-102 ℃ were heated 2 hours down;
(3) medicinal liquid with (2) is under the 600-650 millimeter of water at pressure, carries out vacuum concentration under 85-92 ℃, till concentrated solution is original solution 1/3.
(4) concentrated solution of (3) being packed as every bottle is 10 milliliters, promptly gets oral medication acute cerebrovascular disease medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95117047A CN1053828C (en) | 1995-10-20 | 1995-10-20 | Oral medicine for treating acute cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95117047A CN1053828C (en) | 1995-10-20 | 1995-10-20 | Oral medicine for treating acute cerebrovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1134295A CN1134295A (en) | 1996-10-30 |
| CN1053828C true CN1053828C (en) | 2000-06-28 |
Family
ID=5081117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95117047A Expired - Fee Related CN1053828C (en) | 1995-10-20 | 1995-10-20 | Oral medicine for treating acute cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1053828C (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080861A (en) * | 1993-06-04 | 1994-01-19 | 牛祝琴 | " Naoxuetong " oral liquor and preparation method thereof |
-
1995
- 1995-10-20 CN CN95117047A patent/CN1053828C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080861A (en) * | 1993-06-04 | 1994-01-19 | 牛祝琴 | " Naoxuetong " oral liquor and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 《实用中西医结合杂志》1991年第4卷第2期 1991.1.1 陈启俊等，活血化瘀法治疗老年急性期出血性脑血管病42例报告 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1134295A (en) | 1996-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1330347C (en) | Gongbu ointment | |
| CN103463609A (en) | Traditional Chinese medicine oral decoction for treating upper respiratory infection and preparation method for Chinese patent medicine of traditional Chinese medicine oral decoction | |
| CN114558074A (en) | Traditional Chinese medicine composition for treating metabolic-related fatty liver disease and preparation method and application thereof | |
| CN1087625C (en) | Traditional Chinese medicine preparation for treating colitis | |
| CN101757312A (en) | Chinese medicine preparation for treating thrombocytopenia | |
| CN1367003A (en) | Medicine for curing AIDS | |
| CN1053828C (en) | Oral medicine for treating acute cerebrovascular disease | |
| CN1050299C (en) | Decoction for lowering glucose in urine and quenching thirst | |
| CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN113041324A (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type diabetic nephropathy and preparation method thereof | |
| CN1059336C (en) | Oral liquor for curing senile dementia and constipation | |
| CN1161131C (en) | Process for preparing antitussive mixture | |
| CN107551022A (en) | Treatment table defends the compound preparation and preparation method of not solid caused nonallergic purpura | |
| CN107519370B (en) | Compound preparation for treating non-allergic purpura caused by deficiency of spleen and kidney and preparation method thereof | |
| CN1128663A (en) | Chinese proprietary for treating scapulohumeral periarthritis and prepn. method thereof | |
| CN112206279B (en) | Traditional Chinese medicine composition for treating ventricular arrhythmia and preparation method and application thereof | |
| CN103638469B (en) | A kind of Chinese medicine for the treatment of coronary heart disease | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN1201754C (en) | Chinese medicine prepn for giving up drinking and its prepn process | |
| CN111097016A (en) | Preparation for preventing and treating influenza and preparation method thereof | |
| CN112494539A (en) | A Chinese medicinal composition for treating diabetes, and its preparation method | |
| CN104587397A (en) | Traditional Chinese medicinal composition for treating endocrine dyscrasia | |
| CN104107351A (en) | Chinese herbal medicine for blood fat reducing, and administration method thereof | |
| CN1050288C (en) | Traditional Chinese medicine oral liquid for treating soft tissue pain of waist and legs | |
| CN1075083A (en) | Treatment vasculitis electuary and its method for making |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |